In a landmark fusion of biotechnology and dermatological science, Delavie Sciences, in collaboration with researchers from Harvard Medical School, has announced the launch of its latest proprietary innovation: Hydrolytic Enzyme Complex (HEC). This patented ingredient is poised to redefine how cleansing and exfoliation are approached in high-performance skincare.

Derived from a heat-loving extremophile organism that thrives in temperatures above 130°F, HEC offers a rare enzymatic profile that enables deep cleansing without disrupting the skin’s microbiome or compromising barrier integrity.

HEC has demonstrated exceptional efficacy across multiple skin health metrics:

– Removes 77% of facial sebum after a single application 

– Reduces skin scaliness by 46% 

– Improves elasticity by up to 39% and firmness by 12% 

– Boosts Type I collagen by 37% and skin cell viability by 26%

Unlike harsh surfactants such as sodium dodecyl sulfate (SDS), HEC delivers comparable cleansing power while remaining gentle and microbiome-friendly, making it ideal for oily, acne-prone, and combination skin types.

“This ingredient represents a new era of functionality in skincare,” said Dr. Kyle Landry, President and Co-founder of Delavie Sciences. “HEC delivers tactile results and supports long-term skin health at the cellular level”. HEC will serve as the cornerstone of Delavie’s upcoming product line, set to launch soon, targeting oil control, texture refinement, and barrier repair.